JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.34% |
| 2 | Technology | 11.83% |
| 3 | Healthcare | 9.48% |
| 4 | Consumer Discretionary | 7.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GMLP
1626
DELISTED
Golar LNG Partners LP
GMLP
| $15.1M | ﹤0.01% |
666,827
+181,868
| +38% | +$3.88M |
|
|
BIVV
1627
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $15.1M | ﹤0.01% |
265,602
+1,595
| +0.6% | +$93.4K |
|
|
NBL
1628
DELISTED
Noble Energy, Inc.
NBL
| $15M | ﹤0.01% |
531,558
-130,140
| -20% | -$3.43M |
|
1629
Sarepta Therapeutics
SRPT
$1.81B
| $15M | ﹤0.01% |
317,800
+41,975
| +15% | +$1.68M |
|
|
ROIC
1630
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $15M | ﹤0.01% |
786,998
-143,375
| -15% | -$2.85M |
|
1631
Trinity Industries
TRN
$2.3B
| $15M | ﹤0.01% |
667,059
+182,791
| +38% | +$3.77M |
|
1632
Qorvo
QRVO
$8.56B
| $15M | ﹤0.01% |
213,124
+30,659
| +17% | +$2.14M |
|
1633
Caleres
CAL
$486M
| $15M | ﹤0.01% |
488,813
-56,239
| -10% | -$1.52M |
|
1634
St. Joe Company
JOE
$3.77B
| $14.9M | ﹤0.01% |
774,961
+416,198
| +116% | +$7.73M |
|
|
HMSY
1635
DELISTED
HMS Holdings Corp.
HMSY
| $14.9M | ﹤0.01% |
747,017
+2,878
| +0.4% | +$53.5K |
|
1636
PUT
Incyte
INCY
$24.6B
| $14.8M | ﹤0.01% |
+131,200
| New | +$16.6M |
|
1637
iShares US Oil & Gas Exploration & Production ETF
IEO
$573M
| $14.8M | ﹤0.01% |
251,641
-66,242
| -21% | -$3.6M |
|
1638
F5
FFIV
$23.2B
| $14.8M | ﹤0.01% |
121,925
-14,431
| -11% | -$1.74M |
|
|
AGN
1639
CALL
DELISTED
Allergan plc
AGN
| $14.8M | ﹤0.01% |
72,500
-1,919
| -3% | -$446K |
|
1640
PUT
CSX Corp
CSX
$92.8B
| $14.8M | ﹤0.01% |
825,000
+759,300
| +1,156% | +$13M |
|
1641
PUT
Crown Castle
CCI
$31.3B
| $14.7M | ﹤0.01% |
146,700
+43,200
| +42% | +$4.42M |
|
1642
PUT
Liberty Global Class C
LBTYK
$3.41B
| $14.7M | ﹤0.01% |
460,000
| – | – |
|
1643
CALL
Wells Fargo
WFC
$265B
| $14.7M | ﹤0.01% |
271,700
-1,794,900
| -87% | -$95.4M |
|
1644
New Jersey Resources
NJR
$5.45B
| $14.7M | ﹤0.01% |
347,815
-22,629
| -6% | -$957K |
|
1645
SS&C Technologies
SSNC
$18.7B
| $14.7M | ﹤0.01% |
369,067
+50,885
| +16% | +$1.96M |
|
1646
CALL
Southern Company
SO
$105B
| $14.7M | ﹤0.01% |
300,000
| – | – |
|
1647
Appian
APPN
$2.55B
| $14.7M | ﹤0.01% |
585,018
+127,545
| +28% | +$2.79M |
|
1648
Align Technology
ALGN
$12.5B
| $14.6M | ﹤0.01% |
79,851
-140,900
| -64% | -$24.1M |
|
1649
Trimble
TRMB
$13.6B
| $14.6M | ﹤0.01% |
370,304
+68,984
| +23% | +$2.62M |
|
1650
XPO
XPO
$23.5B
| $14.6M | ﹤0.01% |
636,711
-1,185,697
| -65% | -$24.8M |
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 502 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 502 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.